drugset / Trial / NCT06707090

Tissue Repair Gel in Venous Leg Ulcers (US)

NCT06707090

Phase 3 Recruiting 312 enrolled TR Therapeutics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.

Timeline

Start
2025-01-28
Primary completion
2027-12
Completion
2028-02

Drugs

EvaluationDrugModalityDoseRoute
Subject beta-glucan Other / unclassified 6 mg Topical